[The status quo of pharmacotherapy of lipid metabolism disorders in the aged].
The latest findings of arteriosclerosis and lipid metabolism research have shown that application of medicaments in the treatment of hyper- and dyslipoproteinaemias is necessary also at an advanced age, if dietary treatment fails. A consequent lipid normalisation suggests a decrease of arteriosclerotic effects. The expected benefit must be greater than possible side-effects of lipid regulatives. Lipid regulatives commonly used in the GDR are presented.
Reuter
V W
VW
Gerontologische Abteilung, Klinik für Innere Medizin, Bereichs Medizin der Karl-Marx-Universität Leipzig.
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*
D000960:Hypolipidemic Agents
Status quo der Pharmakotherapie von Fettstoffwechselstörungen im Alter.